» Articles » PMID: 24265765

The Zinc Transporter, Slc39a7 (Zip7) is Implicated in Glycaemic Control in Skeletal Muscle Cells

Overview
Journal PLoS One
Date 2013 Nov 23
PMID 24265765
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Dysfunctional zinc signaling is implicated in disease processes including cardiovascular disease, Alzheimer's disease and diabetes. Of the twenty-four mammalian zinc transporters, ZIP7 has been identified as an important mediator of the 'zinc wave' and in cellular signaling. Utilizing siRNA targeting Zip7 mRNA we have identified that Zip7 regulates glucose metabolism in skeletal muscle cells. An siRNA targeting Zip7 mRNA down regulated Zip7 mRNA 4.6-fold (p = 0.0006) when compared to a scramble control. This was concomitant with a reduction in the expression of genes involved in glucose metabolism including Agl, Dlst, Galm, Gbe1, Idh3g, Pck2, Pgam2, Pgm2, Phkb, Pygm, Tpi1, Gusb and Glut4. Glut4 protein expression was also reduced and insulin-stimulated glycogen synthesis was decreased. This was associated with a reduction in the mRNA expression of Insr, Irs1 and Irs2, and the phosphorylation of Akt. These studies provide a novel role for Zip7 in glucose metabolism in skeletal muscle and highlight the importance of this transporter in contributing to glycaemic control in this tissue.

Citing Articles

T-Cell Receptor Sequences Identify Combined Coxsackievirus- Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus- Infections for Type 1 Diabetes.

Root-Bernstein R Int J Mol Sci. 2024; 25(3).

PMID: 38339075 PMC: 10855694. DOI: 10.3390/ijms25031797.


Zinc homeostasis and redox alterations in obesity.

Franco C, Canzoniero L Front Endocrinol (Lausanne). 2024; 14:1273177.

PMID: 38260166 PMC: 10800374. DOI: 10.3389/fendo.2023.1273177.


Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification.

Luo L, Guan Z, Jin X, Guan Z, Jiang Y Mol Med. 2023; 29(1):36.

PMID: 36941586 PMC: 10029210. DOI: 10.1186/s10020-023-00625-6.


Exploration of novel biomarkers in Alzheimer's disease based on four diagnostic models.

Zou C, Su L, Pan M, Chen L, Li H, Zou C Front Aging Neurosci. 2023; 15:1079433.

PMID: 36875704 PMC: 9978156. DOI: 10.3389/fnagi.2023.1079433.


Modulation of Zinc Transporter Expressions by Additional Zinc in C2C12 Cells Cultured in a High Glucose Environment and in the Presence of Insulin or Interleukin-6.

Ruz M, Andrews-Guzman M, Arredondo-Olguin M Biol Trace Elem Res. 2022; 201(7):3428-3437.

PMID: 36227447 DOI: 10.1007/s12011-022-03443-9.


References
1.
Wijesekara N, Chimienti F, Wheeler M . Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab. 2009; 11 Suppl 4:202-14. DOI: 10.1111/j.1463-1326.2009.01110.x. View

2.
Huang L, Kirschke C, Lay Y, Levy L, Lamirande D, Zhang P . Znt7-null mice are more susceptible to diet-induced glucose intolerance and insulin resistance. J Biol Chem. 2012; 287(40):33883-96. PMC: 3460483. DOI: 10.1074/jbc.M111.309666. View

3.
Hogstrand C, Kille P, Nicholson R, Taylor K . Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med. 2009; 15(3):101-11. DOI: 10.1016/j.molmed.2009.01.004. View

4.
Foster M, Samman S . Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal. 2010; 13(10):1549-73. DOI: 10.1089/ars.2010.3111. View

5.
Cousins R, Liuzzi J, Lichten L . Mammalian zinc transport, trafficking, and signals. J Biol Chem. 2006; 281(34):24085-9. DOI: 10.1074/jbc.R600011200. View